| Company/Division name | Jubilant HollisterStier LLC |
| Parent company | Jubilant Pharmova Ltd. |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2022 |
| Year reshoring implemented or to be implemented: | 2025 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 285 |
| Country(ies) from which reshored: | India |
| City reshored to: | Spokane |
| State(s) reshored to: | WA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | injectable filling |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |
| What domestic positive factors made reshoring more attractive? | Government Incentives, covid |
| Government Incentive dollar amount: | American Rescue Plan, BARDA |
